Director/PDMR Shareholding

RNS Number : 7057G

GlaxoSmithKline PLC

05 March 2018

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, GSK Consumer Healthcare
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	Following the vesting on 2 March 2018 of an award made on 2 March 2015 under the GlaxoSmithKline Deferred Investment Award Plan, Mr McNamara will receive a cash payment of $684,709.84 less applicable tax withholding in respect of 18,967.031 notional ADSs.
c)	Price(s) and volume(s)	Price(s) Volume(s) $36.10 18,967.031
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2018-03-02
f)	Place of the transaction	n/a

 

END

 

 

DSHLELFBVXFBBBL